Clinical Trial: Allogeneic Hematopoietic Cell Transplantation for Refractory Systemic Juvenile Idiopathic Arthritis.

U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07845942) titled 'Allogeneic Hematopoietic Cell Transplantation for Refractory Systemic Juvenile Idiopathic Arthritis.' on Sept. 22.

Brief Summary: The goal of this study is to collect clinical data and samples and to evaluate the feasibility of allogeneic hematopoietic cell transplantation (HCT) in children and young adults with refractory Systemic Juvenile Idiopathic Arthritis (sJIA), including those with sJIA-associated lung disease (sJIA-LD).

Study Start Date: Nov., 2026

Study Type: OBSERVATIONAL

Condition: Refractory Systemic Juvenile Idiopathic Arthritis Systemic Juvenile Idiopathic Arthritis Systemic Juvenile Idiopathic Arthritis Associat...